We're sorry but mesimedical.com page doesn't work properly without JavaScript enabled. Please enable it to continue.
MESI logo
Contact sales
ChatBot
  1. Home
  2. insights
  3. events
  4. easd 2025

EASD 2025


Sep 15 - Sep 19, 2025
LinkedIn icon Facebook icon

Join MESI at EASD 2025 in Vienna

September 15–19, 2025 · Messe Wien Exhibition & Congress Center

Visit our stand C3.04 at the European Association for the Study of Diabetes (EASD) Congress and discover how innovative diagnostics can help prevent amputations and improve outcomes in diabetic patients.

MESI mTABLET

Preventing amputations in diabetes care

Early PAD detection in diabetic patients at risk for better long-term outcomes. MESI mTABLET ABI & TBI enables automated, accurate measurements within minutes as demonstrated in this real-life case where a leg amputation was prevented.

Why it Matters:

  • Complete Arterial Assessment
    Simultaneous ABI and TBI measurement detect PAD even when diabetes-related complications mask symptoms.
  • No Patient Rest Time
    1-minute wireless ABI. Ideal for busy clinical workflows and accessible care.
  • Designed for Nurses
    Seamless, guided protocols support nurse-led screenings in any healthcare setting.
  • Centralised Patient Data
    All results stored and synced in the built-in EHR, enabling full trend review and collaborative care.
  • Instant Reports, Instant Sharing
    Detailed diagnostics are available for quick consultation and faster clinical decisions.

Better Tools, Better Outcomes

Early detection of Peripheral Arterial Disease (PAD) is key to preventing amputations and managing cardiovascular risk in diabetic patients.